InsidersTradesSigma
Follow the 압타머사이언스 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 압타머사이언스 has recorded 3 public disclosures. Market capitalisation: €58bn. The latest transaction was disclosed on 22 April 2026 (Purchase). Among the most active insiders: Wellnew&Co.. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
Aptamer Science es una empresa del sector sanitario y farmacéutico, que cotiza en el mercado XKRX. Se centra en el desarrollo de terapias basadas en aptámeros para diversas enfermedades.